T45.AX5S is a new billable/specific and POA-exempt diagnosis code introduced in the 2025 ICD-10-CM used to classify the following condition: Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela.
Versions
2025
New code
T45.AX5S is a new billable/specific and POA-exempt diagnosis code introduced in the 2025 ICD-10-CM used to classify the following condition: Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela.
New code